Recent Insider Transactions - Fate Therapeutics (NASDAQ: FATE) - Health Stocks Hub

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ FATE Fate Therapeutics

Redmile Group, LLC / director, 10 percent owner:

12/12/2024

Buy

$0.001

30,110

$30

12.83M

Research Tools

News & Announcements

Popular Topics

Miscellaneous